Search Results for: Avandia

Featured Stories

Tentative Ohio Fracking Regulations Criticized as too Lax

Lawmakers in Ohio have tentatively passed new regulations governing hydraulic fracturing (fracking) drilling but they’ve immediately been criticized for being too favorable to the natural gas and oil industries.

Read More

Research Study Confirms Fracking Cause of Ohio Earthquakes

Research Study Confirms Fracking as Cause of Ohio Earthquakes

Fracking operation near Poland Township, Ohio, activated a previously unknown fault in the, causing 77 earthquakes with magnitudes ranging from 1.0 to 3.0 in March 2014.

Read More

Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions

Johnson & Johnson and its Ethicon unit are again coming under scrutiny for the way it marketed its Gynecare ProLift transvaginal mesh product. According to a new report from Bloomberg News, Johnson & Johnson continued marketing the Gynecare ProLift device for months after it received a warning from the ...

Read More

FDA Metal-On-Metal Hip Replacement Investigation Is Flawed, Researchers Say

The U.S. Food & Drug Administration’s (FDA) metal-on-metal hip replacement investigation is flawed, according to researchers.

Read More

Estate of Kentucky Man Alleges Wrongful Death Due to Actos Bladder Cancer

National law firm, Parker Waichman LLP, just filed a lawsuit on behalf of the estate of a Kentucky man who developed bladder cancer and subsequently died, allegedly due to the use of diabetes drug, Actos. The lawsuit names Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, ...

Read More

Scientist Calls for Federal Regulations for Fracking Pollution

Hydraulic fracturing (fracking) drilling should be governed by federal regulations because its pollution has no awareness of state boundaries.

Read More

National Law Firms Calls for More FDA Action on Actos Bladder Cancer Threat

A national law firm is not satisfied with the way the U.S. Food & Drug Administration (FDA) has handled warnings regarding Actos (pioglitazone) bladder cancer risks. In a statement published today, Parker Waichman LLP called on the FDA to compel Takeda Pharmaceuticals, the maker of the type 2 diabetes drug, ...

Read More

Actos Whistleblower Lawsuit Questions Avandia Researcher's Financial Ties to Takeda

A prominent researcher has been implicated in an alleged cover-up of Actos side effects, according to a report from An Actos whistleblower lawsuit unsealed earlier this year has alleged financial connections between the Cleveland Clinic’s Dr Steven Nissen and the maker of Actos “should be considered when analyzing Actos’s ...

Read More

Johnson & Johnson Facing More Metal-on-Metal Hip Implant Woes, as DePuy Pinnacle Complaints Rise

Having already spent around $3 billion on its DePuy Orthopaedics ASR hip implant recall, Johnson & Johnson is facing another potential debacle involving a metal-on-metal version of its Pinnacle Hip Replacement System. According to a report from Reuters, Johnson & Johnson and its DePuy unit already face some 1,600 metal-on-metal ...

Research Suggest Fracking Chemicals Can Pollute Aquifers

A new study suggests fluids used during the hydraulic fracturing (fracking) process could migrate through underground fractures and contaminate water aquifers.

Read More

Avandia Test Lawsuit Settled

An < "">Avandia lawsuit that was expected to be a test case for the thousands of similar claims pending throughout the U.S. was settled on the eve of trial. GlaxoSmithKline, the maker of Avandia, had already settled around 10,000 Avandia … Continue reading

Posted in Legal News | Tagged , , , , , |

First Avandia Trial Underway in Philadelphia

The litigation surrounding < "">Avandia is finally underway. The first federal trial involving an Avandia heart attack lawsuit began yesterday. According to a Daily Finance report, GlaxoSmithKline, the maker of Avandia, has already settled around 10,000 such claims, but it … Continue reading

Posted in Avandia, Pharmaceuticals |

Avandia Poses Serious Heart Risks

Type 2 diabetes drug, < "">Avandia, has long been connected to significant risks of heart attack, strokes, and heart failure. As a matter-of-fact, this September 2010, the U.S. Food & Drug Administration (FDA) placed severe restrictions on Avandia, citing these … Continue reading

Posted in Avandia, Pharmaceuticals |

Avandia Subject to Restrictions in Canada

Health Canada just announced important new restrictions on the use of the following rosiglitazone products due to information on cardiovascular related events: < "">Avandia, Avandamet and Avandaryl. GlaxoSmithKline Inc., in consultation with Health Canada, released important new restrictions on the … Continue reading

Posted in Avandia, Pharmaceuticals |

Avandia Black Box Warning Wasn’t Heeded by All Doctors, Study Finds

Not all doctors are heeding warnings for < "">Avandia. According to a study published in The New England Journal of Medicine that used Avandia as an example, doctors’ prescribing patterns vary across the country in response to warnings about medications … Continue reading

Posted in Pharmaceuticals |

Avandia Faces Justice Department Probe

< "">Avandia, GlaxoSmithKline’s controversial diabetes drug, is coming under more scrutiny. According to a Wall Street Journal report, the drug maker has disclosed that it has been subpoenaed by the US Department of Justice over Avandia. According to Glaxo’s third-quarter … Continue reading

Posted in Avandia, Pharmaceuticals |

Avandia, Bisphosphonate Problems Point to Weaknesses in Drug Approval Process

Recent safety issues involving the diabetes drug < "">Avandia and a class of bone drugs called < "">bisphosphonates have some questioning the way drugs are approved for sale in the US. According to a recent New York Times’ news analysis, … Continue reading

Posted in Avandia, Pharmaceuticals |

Avandia Alternatives Available

With the US Food and Drug Administration (FDA) severely restricting access to the diabetes medication, < "">Avandia, and the European Medicines Agency suggesting the controversial medication be banned, many diabetics are left wondering about safe alternatives. As we have written … Continue reading

Posted in Avandia, Pharmaceuticals |

GlaxoSmithKline Outlook Falls Following Avandia Restrictions

GlaxoSmithKline’s < "">Avandia problems are expected to take a toll on the drug maker’s bottom line. According to a Reuters report, analysts have already begun cutting Glaxo’s earnings forecast, after regulators in the US and Europe announced separate actions that … Continue reading

Posted in Avandia, Pharmaceuticals |

Avandia Severely Restricted by FDA

Citing heart risks from < "">Avandia, the US Food & Drug Administration (FDA) has decided to place severe restrictions on the controversial diabetes drug. According to The New York Times, patients in the US will only have access to Avandia … Continue reading

Posted in Avandia, Pharmaceuticals |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.